IMPORTANCE The treatment of epistaxis is variable. It is important to analyze the effect of the available interventions on patient outcomes. OBJECTIVE To determine demographic, management, and outcome trends in patients admitted with a primary diagnosis of epistaxis and treated with conservative management, nasal packing, arterial ligation, or embolization. DESIGN, SETTING, AND PARTICIPANTS...

A 50-year-old man, with no previous history of epistaxis, was hospitalized at our facility for left recurrent posterior epistaxis. The patient underwent surgical treatment three times and only the operator's experience and radiological support (cranial angiography) allowed us to control the epistaxis and stop the bleeding. The difficult bleeding management and control was attributed to an abnor...

Epidermal growth factor receptor inhibitors (EGFRIs) have become an integral part of therapy for many types of solid malignancy, including colorectal cancer. The drug class has proven to be effective without causing many of the side-effects associated with chemotherapy or other growth factor receptor inhibitors. Epistaxis, a common side-effect of Vascular Endothelial Growth Factor inhibitors, i...

Post-traumatic pseudoaneurysms of internal carotid arteries are uncommon. The patients may present with massive epistaxis due to rupture of the aneurysm into the sphenoid sinus. Early diagnosis and treatment is mandatory as the likelihood of exsanguinations increases with each subsequent episode of epistaxis. The clinical features of unilateral blindness and massive epistaxis after head injury ...

Topical intranasal steroid spray is often used to treat allergic and nonallergic rhinitis, and epistaxis is a common side effect. The prospective, observational study described was designed to determine the incidence of epistaxis and the relationship between the side of bleeding and the hand used to administer the spray, as well as the handedness of the patient, in a noninvestigational, real-wo...

BACKGROUND Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disease that results in telangiectasia of the sinonasal tract, gastro-intestinal tract as well as possible arteriovenous malformations of the lung, liver and brain. One of the most common disease manifestations of HHT is epistaxis. Severe recurrent epistaxis necessitating iron therapy and blood transfusion is often ...

Abstract It is an autosomal dominant vascular disorder, which has a variety of clinical manifestations, with epistaxis being one of the most common. Many treatment options exist for epistaxis, but with no consensus on which is the method of choice. We describe the case of a patient with hereditary hemorrhagic telangiectasia (HHT) secondary epistaxis with septoplasty managed with synthetic hard ...

It is an autosomal dominant vascular disorder, which has a variety of clinical manifestations, with epistaxis being one of the most common. Many treatment options exist for epistaxis, but with no consensus on which is the method of choice. We describe the case of a patient with hereditary hemorrhagic telangiectasia (HHT) secondary epistaxis with septoplasty managed with synthetic hard graft, wh...

Familial epistaxis is often encountered by Otolaryngologists. Osier in 1901 described a triad of symptoms consisting of epistaxis, positive family history and multiple telangiectasia. Harrison (1957) regards this phenomena as 'rare' and Mc Caffrey et al. (1977) calls it unusual Multiple Telangiectasia, the cause of which is unknown, has a dominant familial trait. It may be very easily missed wh...

The syndrome of delayed epistaxis and monocular blindness following nonpenetrating head injury is reviewed. Bleeding results from rupture of a traumatic cavernous internal carotid artery aneurysm into the sphenoid sinus. There were 96 patients with this syndrome found in the literature and another four are added in this report. In 73% of the patients, the cause of the epistaxis was not apprecia...